Altria (MO) Up 7.2% Since Last Earnings Report: Can It Continue?

Altria (MO) reported Q2 2025 results, with adjusted EPS of $1.44 (up 8.3% YoY) and net revenues of $6.102 billion (down 1.7% YoY), both surpassing consensus estimates. The company narrowed its full-year 2025 adjusted EPS guidance to $5.35-$5.45, implying 3-5% growth, driven by strong oral tobacco performance and pricing power which partially offset a 10.2% decline in domestic cigarette shipment volumes. Despite the earnings beat and a 7.2% stock gain since the report, analyst estimates have trended downward, resulting in a Zacks Rank #3 (Hold) and an expectation of in-line returns, suggesting a cautious outlook for the stock's near-term trajectory.

Analysis

Altria's second-quarter 2025 results present a bifurcated picture of operational resilience and underlying secular decline. The company surpassed consensus estimates, delivering an 8.3% year-over-year increase in adjusted EPS to $1.44, driven by aggressive pricing, cost management, and share repurchases. This financial engineering successfully translated into expanded adjusted OCI margins in both the smokeable (to 64.5%) and oral tobacco (to 68.7%) segments. However, this profitability masks a severe deterioration in the core smokeable products business, which saw domestic cigarette shipment volumes plummet by 10.2% due to competition from illicit e-vapor products and eroding consumer discretionary income. While the oral tobacco segment offered a partial offset with a 5.9% revenue increase, its own shipment volumes also contracted by 1%. Management expressed confidence by narrowing its full-year EPS guidance to $5.35-$5.45, implying 3-5% growth, and continued robust capital returns with $1.7 billion in dividends paid. Nevertheless, the recent 7.2% stock rally contrasts sharply with a downward trend in analyst estimates and a neutral Zacks Rank #3 (Hold), signaling that the market's initial optimism may be tempered by the fundamental challenge of offsetting accelerating volume declines with pricing power alone.

Key Decisions for Investors

• Income-oriented investors may find the strong dividend and share buyback program appealing, supported by the narrowed full-year EPS guidance, but must recognize the significant risk posed by the accelerating 10.2% decline in cigarette volumes.
• Investors should scrutinize the sustainability of the company's pricing power as its primary profit driver, as the severe volume contraction suggests this strategy may face increasing pressure.
• Given the stock's 7.2% post-earnings rally juxtaposed with downward trending analyst estimates, it may be prudent to exercise caution, as near-term upside could be limited until there is greater clarity on stabilizing volumes or favorable regulatory developments.